Inflamatory bowel disease (Crohn'S and ulcerative colitis)
Clinical trials for Inflamatory bowel disease (Crohn'S and ulcerative colitis) explained in plain language.
Never miss a new study
Get alerted when new Inflamatory bowel disease (Crohn'S and ulcerative colitis) trials appear
Sign up with your email to follow new studies for Inflamatory bowel disease (Crohn'S and ulcerative colitis), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Biologic showdown: which IBD drug works best after a year?
Disease control Not yet recruitingThis study will follow 95 adults with moderate-to-severe Crohn's disease or ulcerative colitis in Upper Egypt who are taking one of five biologic drugs: adalimumab, infliximab, ustekinumab, golimumab, or vedolizumab. After one year, researchers will measure how many patients avoi…
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New hope for IBD: IL-23 drugs tested in chinese patients
Disease control Not yet recruitingThis study will follow 178 Chinese adults with Crohn's disease or ulcerative colitis who are starting treatment with IL-23 inhibitors (guselkumab or risankizumab). Researchers will track how well the drugs control symptoms and heal the gut over 52 weeks, as well as any side effec…
Matched conditions: INFLAMATORY BOWEL DISEASE (CROHN'S AND ULCERATIVE COLITIS)
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 18:58 UTC